The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmigo Regulatory News (AMGO)

Share Price Information for Amigo (AMGO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.225
Bid: 0.20
Ask: 0.25
Change: 0.00 (0.00%)
Spread: 0.05 (25.00%)
Open: 0.23
High: 0.23
Low: 0.225
Prev. Close: 0.225
AMGO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Capital Raise and Scheme of Arrangement

10 Mar 2023 07:36

RNS Number : 5620S
Amigo Holdings PLC
10 March 2023
 

10 March 2023

Amigo Holdings PLC

 

Update on Capital Raise and Scheme of Arrangement

Amigo Holdings PLC ("Amigo" or "the Company"), a provider of mid-cost credit in the UK,

announced a Scheme of Arrangement, sanctioned by the High Court in May 2022, which contains a Preferred Solution which is conditional on the completion of a 19:1 capital raise by 26 May 2023, followed by the contribution of a minimum £15m payment to the Scheme fund for creditor redress.

 

Unfortunately, following extensive engagement with a large base of potential investors since commencing a marketing process in October 2022, ongoing conversations with potential equity investors over providing the full publicly stated equity capital requirement of £45m concluded on Wednesday evening, and the Company has not received sufficient aggregate indications of interest to cover the total amount.

 

Whilst the Board continues to remain open to proposals, it believes that this target is unlikely to be achieved by 26 May 2023 to allow the continuation of the business under the terms of the Preferred Solution.

 

To date, Amigo has received:

· indicative proposals sufficient to finance its debt requirements; and

· indications of interest in equity capital subscriptions to fund £21m, comprising £11m in ordinary share capital and £10m in exchangeable notes.

 

In the light of the indications of interest received and investor feedback, Amigo is exploring:

· modifying its business plan to reduce working capital requirements by up to £3m; and

· whether a potential new scheme, to eliminate the £15m capital commitment to Scheme creditors, is likely to succeed.

 

The working capital requirement reduction, taken together with the effect of a new scheme, if sanctioned, could reduce the overall equity capital requirement from the anticipated Capital Raise from the current £45m to approximately £27m, leaving a shortfall on current indicative interest of £6m, which would need to be provided by existing shareholders and other as yet unidentified investors. Any new scheme would not impact the £97m committed to the Scheme, which will remain available for Scheme creditors to share pro rata to their adjudicated claims. The proposed timetable of payments to creditors would also remain the same.

 

Danny Malone, CEO of Amigo said: "The Board is very conscious of its duties to its shareholders and

wider stakeholders, including Scheme creditors. As we assess the viability of a new scheme, our

minds remain focused on a go forward solution for the Company where existing shareholders retain

some value but where Scheme creditors can benefit beyond the Fallback Solution. This is a very challenging situation and the Board may conclude that another new scheme is not feasible, but we

believe it is important to explore fully and swiftly before reaching a conclusion."

 

Any new scheme would require approval by the High Court and by creditors, in the same way as the current Scheme. There is no certainty that a new scheme would be approved by creditors and the Court, or that this route will be pursued by the Board once the prospects of achieving a scheme have been further examined. The Board is then bound to immediately switch to the Fallback Solution under the current Scheme which comprises an orderly wind-down of the business, if the Board expects the Capital Raise cannot be completed successfully by 26 May 2023. We are currently engaged with the FCA.

 

A further announcement will be made as soon as practicable.

 

Unless the context otherwise requires, capitalised terms in this announcement shall have the meanings ascribed to them on the announcement by the Company dated 23 February 2023.

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014. The person responsible for this announcement is Roger Bennett, Company Secretary.

ENDS

 

Enquiries

Company

 

Amigo Holdings PLC

investors@amigo.me

Kate Patrick

Investor Relations Director

Roger Bennett

Company Secretary 

 

 

Media enquiries 

Amigoloans@lansons.com

Tony Langham

07979 692287

Peel Hunt LLP

020 7418 8900

James Britton

Oliver Jackson

Ashcombe Advisers LLP

020 7529 5800

Andreas Wesemann

 

Josh Black

 

About Amigo Loans

Amigo is a public limited company registered in England and Wales with registered number 10024479. The Amigo Shares are listed on the Official List of the London Stock Exchange. Amigo offers mid-cost personal loans under its RewardRate brand. The RewardRate products reward customers for on-time payments with an annual, interest-free, payment holiday and the opportunity to reduce the effective APR, encouraging better financial management and facilitating a long-term improvement of customers' credit scores and financial mobility. Amigo offers access to mid‐cost credit to those who were unable to borrow from traditional lenders due to their credit histories. Amigo's back book of loans issued pre-November 2020 is in the process of being run off with all net proceeds due to creditors under the Court approved Scheme of Arrangement. Amigo Loans Ltd and Amigo Management Services Ltd are authorised and regulated in the UK by the Financial Conduct Authority.

Additional Information

This announcement is not intended to, and does not, constitute or form part of any offer, invitation, or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell, or otherwise dispose of, any securities, or the solicitation of any vote or approval in any jurisdiction, pursuant to this announcement or otherwise.

This announcement constitutes notice by Amigo Luxembourg S.A. (the "Issuer") to the holders of the Issuer's 7.625% Senior Secured Notes due 2024 (for the notes issued pursuant to Rule 144A of the United States Securities Act of 1933, ISIN: XS1533928468 and Common Code: 153392846; for the notes issued pursuant to Regulation S of the United States Securities Act of 1933, ISIN: XS1533928625 and Common Code: 153392862) (the "Notes") issued pursuant to pursuant to Section 4.03(a)(3) of an indenture dated January 20, 2017 among, inter alia, the Issuer, the guarantors named therein and U.S. Bank Trustees Limited, as trustee and security agent. Amigo Holdings PLC is the indirect parent company of the Issuer. This announcement shall constitute a "Report" to holders of the Notes.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFZGMFNGFGFZG
Date   Source Headline
9th Apr 20247:00 amRNSGeneral Meeting
5th Apr 20248:05 amRNSAdmission of Shares
28th Mar 20247:00 amRNSAppointment of strategic consultant
18th Dec 20237:00 amRNSInterim Financial Results
14th Dec 20231:00 pmRNSNotice of Results
30th Nov 20232:00 pmRNSBoard and Company Secretary Change
20th Nov 20233:15 pmRNSStandard form for notification of major holdings
17th Nov 20238:39 amRNSListing Restoration & Resumption of Share Trading
17th Nov 20238:05 amRNSListing Restoration & Resumption of Share Trading
17th Nov 20237:00 amRNSStandard form for notification of major holdings
16th Nov 20237:00 amRNSTermination of Potential Transaction
17th Oct 20237:43 amRNSProposed transaction and suspension of listing
17th Oct 20237:30 amRNSSuspension - Amigo Holdings PLC
27th Sep 20233:30 pmRNSResult of AGM
27th Sep 20237:00 amRNSAGM Statement
4th Sep 20233:55 pmRNSNotice of AGM
14th Aug 20235:00 pmRNSAnnual Report and Accounts
27th Jul 20237:00 amRNSFinancial Results for the year ended 31 March 2023
15th Jun 20232:18 pmRNSChange of Registered Office
9th Jun 20237:00 amRNSMarket Update
16th May 20237:00 amRNSBoard change
19th Apr 20237:00 amRNSStatement re. share price movement
3rd Apr 20237:00 amRNSEmployee Share Schemes & Total Voting Rights
3rd Apr 20237:00 amRNSUpdate on Senior Secured Loan Notes
30th Mar 20234:40 pmRNSSecond Price Monitoring Extn
30th Mar 20234:35 pmRNSPrice Monitoring Extension
30th Mar 20233:22 pmRNSUpdate on corporate broker
29th Mar 20234:35 pmRNSPrice Monitoring Extension
29th Mar 20232:05 pmRNSSecond Price Monitoring Extn
29th Mar 20232:00 pmRNSPrice Monitoring Extension
28th Mar 20239:00 amRNSPrice Monitoring Extension
27th Mar 20234:40 pmRNSSecond Price Monitoring Extn
27th Mar 20234:35 pmRNSPrice Monitoring Extension
27th Mar 20231:15 pmRNSBoard changes
23rd Mar 20237:01 amRNSScheme of Arrangement Update
13th Mar 20234:35 pmRNSPrice Monitoring Extension
10th Mar 20237:36 amRNSUpdate on Capital Raise and Scheme of Arrangement
10th Mar 20237:00 amRNSShare Incentive Plan purchase
9th Mar 20234:40 pmRNSSecond Price Monitoring Extn
9th Mar 20234:35 pmRNSPrice Monitoring Extension
8th Mar 20237:00 amRNSGeneral Meeting Statement
7th Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20234:35 pmRNSPrice Monitoring Extension
27th Feb 20234:35 pmRNSPrice Monitoring Extension
23rd Feb 20237:00 amRNS3rd Quarter Results
22nd Feb 20234:40 pmRNSSecond Price Monitoring Extn
22nd Feb 20234:35 pmRNSPrice Monitoring Extension
21st Feb 20234:35 pmRNSPrice Monitoring Extension
16th Feb 20237:00 amRNSNotice of General Meeting
14th Feb 20237:14 amRNSStatement re Conclusion of Enforcement Action

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.